News
Seelhorst currently works at Kindly MD, Inc., as Independent Director from 2024 and Justice Grown, as Senior VP-Compliance & Governmental Affairs from 2018. Mr. Seelhorst also formerly worked at ...
This was the stock's fourth consecutive day of losses.
Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...
Eli Lilly (LLY) stock in focus as the company beats Biogen (BIIB) to win regulatory nod in Australia for first ...
The Tobias and Lechleiter families donated $20 million to establish the Institute for Clinical Innovation at IU Health, the ...
Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
Squeezed by insurers and middlemen, independent pharmacists find themselves on the front lines of a tariff storm.
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was ...
The common theme at the maker of Wegovy and at UnitedHealth may be investors' sudden awareness of cost-cutting pressure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results